NEJM Interviews

audio@nejm.org

For verified host and producer emails, sign up to view.

NEJM Interview: Jean Nachega on the importance of investment in equitable partnerships, community trust, and local scientific leadership for outbreak preparedness.

August 05, 2026

Jean Nachega is a professor of infectious diseases and the director of the Biomedical Research Institute at Stellenbosch University and an associate professor at the University of Pittsburgh School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A. Zumla and Others. Ebola at 50 — Lessons for Outbreak Response and Preparedness. N Engl J Med 2026;395:527-529. S. Tonen-Wolyec and L. Bélec. The Social Contract of Bundibugyo Ebola Isolation. N...

NEJM Interview: Jerry Avorn on the role of litigation in addressing product-related damage to health.

July 29, 2026

Jerry Avorn is a professor of medicine at Harvard Medical School and the codirector of the Program on Regulation, Therapeutics, and Law at Harvard Medical School and Brigham and Women’s Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J. Avorn. Products That Pose Health Risks — Can Litigation Protect Us When Government Fails? N Engl J Med 2026;395:421-423.

NEJM Interview: Arnold Monto on the value and feasibility of various methods for evaluating the protection offered by vaccines.

July 22, 2026

Arnold Monto is a professor emeritus of epidemiology and of public health and codirector of the Center for Respiratory Virus Research and Response at the University of Michigan School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A.S. Monto and H.Y. Chu. The Best of Both Worlds — Using Clinical Trial and Observational Data to Evaluate Vaccine Protection. N Engl J Med 2026;395:313-316.